EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications ; volume:12 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-13 ; date:12.2019
Journal of hematology & oncology ; 12, Heft 1 (21.11.2019), 1-13, 12.2019
- Creator
-
Li, Boheng
Chng, Wee-Joo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-019-0814-6
- URN
-
urn:nbn:de:101:1-2020031722204385923030
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Boheng
- Chng, Wee-Joo
- SpringerLink (Online service)
Other Objects (12)
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies